EVE Health Group Limited
EVE Health Group Limited, together with its subsidiaries, engages in the development, retail, and commercialization of health and wellness, and pharmaceutical products. The company lead product is Dyspro, a proprietary pharmaceutical-grade formulation to address dysmenorrhea (menstrual pain); and Libbo, a proprietary pharmaceutical-grade oral dissolving film formulation for the treatment of erect… Read more
EVE Health Group Limited (EVE) - Total Assets
Latest total assets as of December 2025: AU$4.07 Million AUD
Based on the latest financial reports, EVE Health Group Limited (EVE) holds total assets worth AU$4.07 Million AUD as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
EVE Health Group Limited - Total Assets Trend (2004–2025)
This chart illustrates how EVE Health Group Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
EVE Health Group Limited - Asset Composition Analysis
Current Asset Composition (June 2025)
EVE Health Group Limited's total assets of AU$4.07 Million consist of 27.4% current assets and 72.6% non-current assets.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$903.42K | 21.9% |
| Accounts Receivable | AU$42.27K | 1.0% |
| Inventory | AU$183.96K | 4.5% |
| Property, Plant & Equipment | AU$0.00 | 0.0% |
| Intangible Assets | AU$3.00 Million | 72.6% |
| Goodwill | AU$0.00 | 0.0% |
Asset Composition Trend (2004–2025)
This chart illustrates how EVE Health Group Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: EVE Health Group Limited's current assets represent 27.4% of total assets in 2025, an increase from 15.0% in 2004.
- Cash Position: Cash and equivalents constituted 21.9% of total assets in 2025, up from 10.6% in 2004.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 72.0% of total assets, an increase from 0.0% in 2004.
- Asset Diversification: The largest asset category is intangible assets at 72.6% of total assets.
EVE Health Group Limited Competitors by Total Assets
Key competitors of EVE Health Group Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
General Mills Inc
NYSE:GIS
|
USA | $32.55 Billion |
|
B&G Foods Inc
NYSE:BGS
|
USA | $2.94 Billion |
|
Tangrenshen Group Co Ltd
SHE:002567
|
China | CN¥17.90 Billion |
|
Shenzhen Shenbao Industrial Co Ltd
SHE:000019
|
China | CN¥7.01 Billion |
|
Xiwang Foodstuffs Co Ltd
SHE:000639
|
China | CN¥6.08 Billion |
|
Nanfang Black Sesame Group Co Ltd
SHE:000716
|
China | CN¥4.57 Billion |
|
CNFC Overseas Fishery Co Ltd
SHE:000798
|
China | CN¥5.88 Billion |
|
Henan Shuanghui Investment & Development Co Ltd
SHE:000895
|
China | CN¥40.64 Billion |
EVE Health Group Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - EVE Health Group Limited generates 0.42x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - EVE Health Group Limited is currently not profitable relative to its asset base.
EVE Health Group Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.48 | 1.85 | 10.95 |
| Quick Ratio | 3.15 | 1.44 | 9.24 |
| Cash Ratio | 0.00 | 0.79 | 8.53 |
| Working Capital | AU$762.50K | AU$ 417.11K | AU$ 5.80 Million |
EVE Health Group Limited - Advanced Valuation Insights
This section examines the relationship between EVE Health Group Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.59 |
| Latest Market Cap to Assets Ratio | 0.43 |
| Asset Growth Rate (YoY) | 63.5% |
| Total Assets | AU$4.12 Million |
| Market Capitalization | $1.78 Million USD |
Valuation Analysis
Below Book Valuation: The market values EVE Health Group Limited's assets below their book value (0.43 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: EVE Health Group Limited's assets grew by 63.5% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for EVE Health Group Limited (2004–2025)
The table below shows the annual total assets of EVE Health Group Limited from 2004 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | AU$4.12 Million | +63.49% |
| 2024-06-30 | AU$2.52 Million | -38.97% |
| 2023-06-30 | AU$4.13 Million | -48.79% |
| 2022-06-30 | AU$8.07 Million | -32.30% |
| 2021-06-30 | AU$11.92 Million | -15.51% |
| 2020-06-30 | AU$14.11 Million | +60.77% |
| 2019-06-30 | AU$8.78 Million | +17.72% |
| 2018-06-30 | AU$7.46 Million | +142.81% |
| 2017-06-30 | AU$3.07 Million | +59.74% |
| 2016-06-30 | AU$1.92 Million | -30.67% |
| 2015-06-30 | AU$2.77 Million | -66.14% |
| 2014-06-30 | AU$8.19 Million | -0.82% |
| 2013-06-30 | AU$8.26 Million | -65.13% |
| 2012-06-30 | AU$23.68 Million | -11.23% |
| 2011-06-30 | AU$26.68 Million | +1.13% |
| 2010-06-30 | AU$26.38 Million | +13.06% |
| 2009-06-30 | AU$23.33 Million | -13.04% |
| 2008-06-30 | AU$26.83 Million | +38.14% |
| 2007-06-30 | AU$19.42 Million | +208.44% |
| 2006-06-30 | AU$6.30 Million | +152.24% |
| 2005-06-30 | AU$2.50 Million | +531.49% |
| 2004-06-30 | AU$395.33K | -- |